A life sciences company’s value in its early stages is tied to its IP, its protection, and its freedom to operate (FTO). It is critical that life sciences company founders and managers understand that decisions made about IP positioning, timing, and protection can affect the prospects for raising capital. The Legal:GPS Web conference discussed key issues, such as: IP defense types, strategies to follow, excluding competitors from the marketplace and what potential investors can uncover during the due diligence and FTO analyses.
Director of Business Development, Purdue Research Foundation & Discovery Park
Michele M. Simkin
Partner and Chair, Biotechnology & Pharmaceutical Practice, Foley & Lardner LLP
President, Springboard Enterprises